Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pawel Muranski

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Investigation|November 8, 2011
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumorsSid P Kerkar, Romina S Goldszmid, Pawel Muranski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Toll-like receptors in tumor immunotherapyChrystal M Paulos, Andrew Kaiser, Claudia Wrzesinski, et al.
The New England Journal of Medicine|April 11, 2019
Pembrolizumab Treatment for Progressive Multifocal LeukoencephalopathyIrene Cortese, Pawel Muranski, Yoshimi Enose-Akahata, et al.
The Journal of Clinical Investigation|October 5, 2013
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor functionMadhusudhanan Sukumar, Jie Liu, Yun Ji, et al.
Nature Immunology|November 8, 2011
Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cellsYun Ji, Zoltan Pos, Mahadev Rao, et al.
Cancer Research|July 22, 2010
Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hostsSid P Kerkar, Pawel Muranski, Andrew Kaiser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2016
Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic AnemiaKohei Hosokawa, Pawel Muranski, Xingmin Feng, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studiesSid P Kerkar, Luis Sanchez-Perez, Shicheng Yang, et al.
Blood|March 21, 2008
Tumor-specific Th17-polarized cells eradicate large established melanomaPawel Muranski, Andrea Boni, Paul A Antony, et al.
Bone Marrow Transplantation|November 12, 2014
Clinical and biological predictors of outcome following relapse of CML post-allo-SCTNatasha A Jain, Sawa Ito, Xin Tian, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Investigation|November 8, 2011
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumorsSid P Kerkar, Romina S Goldszmid, Pawel Muranski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Toll-like receptors in tumor immunotherapyChrystal M Paulos, Andrew Kaiser, Claudia Wrzesinski, et al.
The New England Journal of Medicine|April 11, 2019
Pembrolizumab Treatment for Progressive Multifocal LeukoencephalopathyIrene Cortese, Pawel Muranski, Yoshimi Enose-Akahata, et al.
The Journal of Clinical Investigation|October 5, 2013
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor functionMadhusudhanan Sukumar, Jie Liu, Yun Ji, et al.
Nature Immunology|November 8, 2011
Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cellsYun Ji, Zoltan Pos, Mahadev Rao, et al.
Cancer Research|July 22, 2010
Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hostsSid P Kerkar, Pawel Muranski, Andrew Kaiser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2016
Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic AnemiaKohei Hosokawa, Pawel Muranski, Xingmin Feng, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studiesSid P Kerkar, Luis Sanchez-Perez, Shicheng Yang, et al.
Blood|March 21, 2008
Tumor-specific Th17-polarized cells eradicate large established melanomaPawel Muranski, Andrea Boni, Paul A Antony, et al.
Bone Marrow Transplantation|November 12, 2014
Clinical and biological predictors of outcome following relapse of CML post-allo-SCTNatasha A Jain, Sawa Ito, Xin Tian, et al.
Pageof 7